Tuesday , December 12 2017
Home / Resources (page 1311)



NEW Warnings Added to Diabetes Drugs

WASHINGTON, April 26 — GlaxoSmithKline and Eli Lilly & Company have added warnings about heart and liver risks to the labels of their diabetes drugs, which are similar to a medication that was withdrawn from the market in 2000 because of links to fatal liver damage.

Read More »

Insulin’s contribution to obesity

Insulin itself may contribute to obesity. A high first-phase insulin response to intravenous glucose has been shown to be a risk factor for long-term weight gain, and this effect is particularly manifested in insulin-sensitive individuals. 76 Also, compared to normal children, Pima Indian children with elevated fasting insulin gain more …

Read More »